Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Advisors
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
hTERT ICC Test
EXO-NET® Pan-Exosome
Product Technology & Features
Workflow and Performance
Product Ordering
Resources
Pipeline
Development Pipeline
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Conferences & Events
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
INOVIQ in the News
Heading &
Sub-heading can be edited through HQI
Media
>
INOVIQ in the News
INOVIQ in the News
INOVIQ in the News
8-Feb-2023
Sectors mixed as ASX edges 0.35% higher
8-Feb-2023
Stocks of the Hour: Tennant Minerals, Latin Resources, INOVIQ
21-Dec-2022
Passing of Professor Allan Cripps AO
15-Dec-2022
INOVIQ presents at the MST Access Diagnostics Forum
13-Dec-2022
Stocks of the Hour: Kingwest Resources, Doctor Care Anywhere, INOVIQ
28-Nov-2022
China's lockdown rampage causes lower start to ASX
25-Nov-2022
Lithium stocks falling, Critical Minerals Summit commencing: ASX up 0.29% at noon
16-Nov-2022
The Australian: Lots of milestones expected from INOVIQ in 2023 as it aims to commercialise cancer diagnostics products in the US
13-Oct-2022
The Market Herald: INOVIQ signs agreement with Nicoya Lifesciences to develop SubB2M-based test
13-Oct-2022
Financials keeping the local market in the green: ASX up 0.51% at noon
27-Sep-2022
Stockhead Health & Biotech Investment Guide
8-Sep-2022
INOVIQ carving itself healthy share of multi-billion dollar medical diagnostics market
29-Jul-2022
INOVIQ (ASX:IIQ) discusses US milestones
26-Jul-2022
INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma
26-Jul-2022
Energy, miners and BNPL shares lead the way: Aus shares close 0.3% higher
26-Jul-2022
ASX in a holding pattern: Aus shares 0.2% higher at noon
22-Jul-2022
INOVIQ expands US footprint with new sales team
1-Jul-2022
Energy and miners drag ASX lower, down 0.6% over the week
1-Jul-2022
INOVIQ (ASX:IIQ) granted SubB2M US patent for diagnostic applications
22-Apr-2022
Inoviq expands collaboration with UQ to develop exosome-based ovarian cancer screening test
5-Apr-2022
INOVIQ wants to beat cancer to the punch with world-first diagnostic solutions
21-Dec-2021
Bard1 Awarded Biomedical Translation Bridge Funding to Develop Breast Cancer Tests
4-Nov-2021
BARD1 Life Sciences (ASX:BD1) Presentation, FNN Online Investor Event, October 2021
15-Feb-2021
INOVIQ reveals its SubB2M technology can detect all stages of breast cancer from a blood sample, 100% specificity and 95% sensitivity.
14-Feb-2021
INOVIQ share price doubles following positive announcement on ovarian cancer detection technology.
3-Dec-2020
Media release: The Australian Government is backing several Australian research projects aimed at finding breakthrough treatments, diagnostics and a vaccine in the fight against COVID-19.
3-Sep-2020
AusBiotech: Government announces support for COVID-19 research projects
10-Aug-2020
INOVIQ Life Sciences (ASX:BD1) receives European patent validation for cancer tests
24-Apr-2020
INOVIQ Limited was represented at the AACR Annual Meeting 2020 by CSO Dr Irmgard Irminger-Finger who gave an invited oral presentation on 24 April 2020.
23-Oct-2018
Proactive Investors covers INOVIQ breast cancer test announcement today INOVIQ develops world’s first blood test for early detection of breast cancer
23-Oct-2018
Article published by SmallCaps today INOVIQ develops world first blood test for breast cancer detection
21-May-2018
Article published by StocksDigital in nextBIOTECH Top Results: INOVIQ Continues to Boost its Ovarian Cancer Detection Studies
21-May-2018
Article published by finfeed INOVIQ inks critical deal to develop autoantibody test
18-May-2018
Interview of INOVIQ CEO Dr Leearne Hinch by Proactive Investors INOVIQ approaching “important milestone” on path to commercialisation
18-May-2018
Article published by Proactive Investors INOVIQ signs agreement to develop custom research assay
10-Jan-2018
INOVIQ announces positive results from ovarian cancer test
9-Jan-2018
Article published by SMALL CAPS on INOVIQ’s Ovarian Cancer Detection Study
2-Jan-2017
Interview of INOVIQ LSL Executive Director and CSO Dr Irmgard Irminger-Finger by Startwerk “BARD1AG SA: The real fight against lung cancer”